Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb
09:29am, Monday, 11'th May 2026
Moderna Inc. (NASDAQ:MRNA) and Novavax Inc. (NASDAQ:NVAX) shares moved higher Monday as traders piled back into vaccine names following renewed concerns over a hantavirus outbreak tied to the MV Hondi
Hantavirus cases spark surge in pharma and biotech stocks — here's why
07:53am, Monday, 11'th May 2026
Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutions rose in early market trading.
What's Going On With Novavax Stock On Friday?
02:18pm, Friday, 08'th May 2026
Novavax Inc. (NASDAQ:NVAX) stock is trading higher on Friday in reaction to a surge in Moderna Inc. (NASDAQ:MRNA).
Novavax to Participate in BofA Securities 2026 Health Care Conference
04:00pm, Thursday, 07'th May 2026
GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.
NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum
12:16pm, Thursday, 07'th May 2026
Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.
Why Novavax Stock Is Trading Higher On Wednesday?
03:07pm, Wednesday, 06'th May 2026
Novavax Inc. (NASDAQ:NVAX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter financial results.
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
02:21pm, Wednesday, 06'th May 2026
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates
10:30am, Wednesday, 06'th May 2026
Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago.
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
08:00am, Wednesday, 06'th May 2026
Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M ® in two infectious disease areas In April,
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
06:45pm, Friday, 01'st May 2026
Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Friday, 01'st May 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
11:01am, Thursday, 30'th Apr 2026
Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
04:00pm, Wednesday, 29'th Apr 2026
GAITHERSBURG, Md., April 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:06am, Monday, 27'th Apr 2026
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Outperforms Broader Market: What You Need to Know
06:46pm, Friday, 17'th Apr 2026
Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close.
